US Patent Issued to Biossil, Board of Regents of the University of Texas System on Oct. 27 for "Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent" (Missouri, Texas, Iowa Inventors)

Posted On: 2026-10-27

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,411, issued on Oct. 27, was assigned to Biossil Inc. (Toronto) and Board of Regents of the University of Texas System (Austin, Texas).

"Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent" was invented by Jeffery L. Keene (St. Louis), Dennis P. Riley (Chesterfield, Mo.), Robert A. Beardsley (University City, Mo.), Michael Dean Story (Dallas), Kranti Ashok Mapuskar (Iowa City, Iowa), Douglas R. Spitz Jr. (Iowa City, Iowa), Bryan G. Allen (Iowa City, Iowa), Andrew Blake Davis (Iowa City, Iowa) and Diana Zepeda Orozco (Iowa City, Iowa).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Biossil, Board of Regents of the University of Texas System on Oct. 27 for "Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent" (Missouri, Texas, Iowa Inventors)